The Human Host Defense Peptide LL-37 Overexpressed in Lung Cell Lines by Methanolic Extract of Valeriana officinalis
DOI:
https://doi.org/10.1590/s2175-97902023e21025Keywords:
Valerenic acid; Overexpression; Gene; Protein; Upregulation.Abstract
The present study investigated the effects of valerian methanolic extract and valerenic acid on the expression of LL-37 gene and protein in A549 and MRC5 line cells. After preparing Valerian seeds, sowing them in March 2020, and harvesting the rhizome in October 2020, the extract was prepared from the valerian rhizome by maceration method. Valerian acid content was determined using high performance liquid chromatography (HPLC). Two cell lines (A549 and MRC-5) were used to study the effects of valerian extract, and the MTT test was used to evaluate cell viability. The expression of LL-37 mRNA and protein was assessed by Real-Time PCR and western blot, respectively. In vivo safety assessments and histopathological analysis were also conducted. Data was analyzed by Graphpad Prism 8 software. Valerian methanolic extract and valerenic acid upregulated the LL-37 mRNA and protein expression in both treated cell lines. Valerenic acid showed a greater effect on upregulating LL-37 expression than valerian methanolic extract. A549 cells were more sensitive to valerian methanolic extract compared to MRC5 cells, and its cell viability was reduced. Furthermore, liver and kidney-related safety assessments showed that valerian methanolic extract had no toxic effects. In general, it was concluded that the methanolic extract of valerian as well as the resulting valerenic acid as the most important component of the extract has the ability to upregulate LL-37expression. Therefore, methanolic extract of valerian and valerenic acid can be considered for improving the immune system.
Downloads
References
Al-Mousawi AM, Kulp GA, Branski LK, Kraft R, Mecott GA, Williams FN, et al. Impact of anesthesia, analgesia and euthanasia technique on the inflammatory cytokine profile in a rodent model of severe burn injury. Shock (Augusta, Ga). 2010;34(3):261.
Bahar AA, Ren D. Antimicrobial peptides. J Pharm. 2013;6(12):1543-75.
de Miguel Catalina A, Forbrig E, Kozuch J, Nehls C, Paulowski L, Gutsmann T, et al. The C-Terminal VPRTES tail of LL-37 influences the mode of attachment to a lipid bilayer and antimicrobial activity. J Biochem. 2019;58(19):2447-62.
Diaper A, Hindmarch I. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults. Phytother R. 2004;18(10):831-6.
Duke JA. Handbook of medicinal herbs: CRC press; 2002.
Ekhteraei TH, Rajabian T, Ebrahimzadeh H, Niknam V. Enhanced production of valerenic acids and valepotriates by in vitro cultures of Valeriana officinalis L. Int J Plant Prod. 2010;4(3):209-221.
Fabisiak A, Murawska N, Fichna J. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity. Pharmacol Rep. 2016;68(4):802-8.
Jha LL, Shah D, Ks R. Bioproduction of human defensins antimicrobial peptides in transgenic plants. Int J Pharm a Bio Sci. 2012;3(2).
Lau YE, Rozek A, Scott MG, Goosney DL, Davidson DJ, Hancock RE. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun. 2005;73(1):583-91.
Nandhini S, Narayanan KB, Ilango K. Valeriana Officinalis: a review of its traditional uses, phytochemistry and pharmacology. Asian J Pharm Clin Res. 2018;11(1):36-41.
Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011;29(9):464-72.
Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J. 1999;341(3):501-13.
Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, et al. Trends in infectious diseases mortality in the United States. Jama. 1996;275(3):189-93.
Piotto SP, Sessa L, Concilio S, Iannelli P. YADAMP: yet another database of antimicrobial peptides. Int J Antimicrob Agents 2012;39(4):346-51.
Rezaie A, Pashazadeh M, Ahmadizadeh C, Jafari B, Jalilzadeh HM. Study of sedative and anxiolytic effect of herbal extract of Nardostachys jatamansi in comparison with diazepam in Rats. J Med Plant. 2010;4(36):169-74.
Seiler F, Bals R, Beisswenger C. Function of antimicrobial peptides in lung innate immunity. Antimicrobial Peptides: Springer; 2016. p. 33-52.
Stotz H, Waller F, Wang K. Innate immunity in plants: the role of antimicrobial peptides. Antimicrobial peptides and innate immunity: Springer; 2013. p. 29-51.
Wang C-K, Shih L-Y, Chang KY. Large-scale analysis of antimicrobial activities in relation to amphipathicity and charge reveals novel characterization of antimicrobial peptides. Molecules. 2017;22(11):2037.
Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals. 2014;7(5):545-94.
Yang D, Chertov O, Oppenheim JJ. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol. 2001;69(5):691-7.
Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75(1):39-48.
Zasloff M. Antimicrobial peptides of multicellular organisms: my perspective. Antimicrobial Peptides: Springer; 2019. p. 3-6.
Zsila F, Kohut G, Beke-Somfai T. Disorder-to-helix conformational conversion of the human immunomodulatory peptide LL-37 induced by antiinflammatory drugs, food dyes and some metabolites. Int J Biol Macromol. 2019;129:50-60.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
